Genetics

Recent research highlights a growing link between lipid metabolism and neuroinflammatory disorders such as Multiple Sclerosis (MS). This blog post examines findings from a Scientific Reports study that used nuclear magnetic resonance–based lipoprotein profiling to investigate metabolic alterations in patients with relapsing–remitting MS. The study reveals distinct changes in lipoprotein particle size, composition, and functionality—particularly involving low-density and high-density lipoproteins—along with reduced cholesterol efflux capacity and impaired anti-inflammatory properties of HDL. These alterations appear especially pronounced in patients with lower body mass index, suggesting that metabolic dysregulation in MS may extend beyond traditional risk factors like obesity. Understanding these lipid-related changes provides new insights into the interplay between metabolism and immune activity in MS and may open avenues for novel diagnostic biomarkers and therapeutic strategies.